MALFACINI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 852
AS - Asia 168
EU - Europa 66
SA - Sud America 1
Totale 1.087
Nazione #
US - Stati Uniti d'America 851
VN - Vietnam 123
CN - Cina 44
IT - Italia 15
FI - Finlandia 11
GB - Regno Unito 11
DE - Germania 7
SE - Svezia 6
IE - Irlanda 5
NL - Olanda 4
BG - Bulgaria 3
RU - Federazione Russa 2
AR - Argentina 1
CA - Canada 1
FR - Francia 1
JP - Giappone 1
UA - Ucraina 1
Totale 1.087
Città #
Fairfield 275
Dong Ket 123
Seattle 74
Ashburn 58
San Diego 57
Woodbridge 54
Cambridge 50
Wilmington 36
Houston 34
Medford 32
Princeton 32
Roxbury 29
Beijing 20
Des Moines 16
Ann Arbor 13
Helsinki 10
Dublin 5
Legnaro 4
Chandler 3
Ferrara 3
Sofia 3
London 2
Niederzier 2
Ogden 2
Prescot 2
Agordo 1
Bari 1
Borås 1
Chicago 1
Chiswick 1
Deventer 1
Hanover 1
Hounslow 1
Kharkiv 1
Kilburn 1
Lappeenranta 1
Las Vegas 1
Los Angeles 1
Negrar 1
New Bedfont 1
Norwalk 1
Novovarshavka 1
Padova 1
Philadelphia 1
Rockville 1
Rome 1
Rotterdam 1
Selvazzano Dentro 1
Southwark 1
Tokyo 1
Toronto 1
Zhoukou 1
Totale 966
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 148
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 52
Novel Mixed NOP/Opioid Receptor Peptide Agonists 45
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 43
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 41
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 40
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 40
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 40
Pharmacological characterization of tachykinin tetrabranched derivatives 39
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 38
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 37
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 37
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 36
Pharmacological Assays for Investigating the NOP Receptor 34
Pharmacological characterization of naloxegol: In vitro and in vivo studies 34
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 32
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 32
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 32
NOP receptor pharmacological profile – A dynamic mass redistribution study 31
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 31
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity 31
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 30
Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues 30
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 29
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 28
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 26
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 19
Heterologous Expression, Biosynthetic Studies, and Ecological Function of the Selective Gq-Signaling Inhibitor FR900359 14
Lack of beta-arrestin signaling in the absence of active G proteins 13
Unraveling binding mechanism and kinetics of macrocyclic Gαq protein inhibitors 12
GPCR in Adipose Tissue Function-Focus on Lipolysis 9
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 9
Functional selectivity of EM-2 analogs at the mu-opioid receptor 8
Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity 7
(L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky 'Forced-Traceless' Regioselective Pd-Catalyzed C(sp2)-H Activation 4
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors 2
Totale 1.133
Categoria #
all - tutte 6.871
article - articoli 6.694
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 177
Totale 13.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021302 0 0 0 0 0 0 0 0 63 96 9 134
2021/2022623 21 36 34 60 13 10 14 81 15 8 133 198
2022/202376 47 1 2 0 2 6 0 2 1 0 6 9
2023/2024132 0 9 34 21 18 16 23 5 5 1 0 0
Totale 1.133